Article Information
History
- May 30, 2020.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Author Information
- Philip A. Mudd1,*,†,
- Jeremy Chase Crawford2,†,
- Jackson S. Turner3,
- Aisha Souquette2,
- Daniel Reynolds4,
- Diane Bender5,
- James P. Bosanquet6,
- Nitin J. Anand6,
- David A. Striker6,
- R. Scott Martin6,
- Adrianus C. M. Boon4,
- Stacey L. House1,
- Kenneth E. Remy4,7,8,
- Richard S. Hotchkiss4,8,9,
- Rachel M. Presti4,
- Jane A. O’Halloran4,
- William G. Powderly4,
- Paul G. Thomas2,* and
- Ali H. Ellebedy3,4,5,*
- 1Department of Emergency Medicine, Washington University School of Medicine, Saint Louis, MO, USA
- 2Department of Immunology, St. Jude Children’s Research Hospital, Memphis, TN, USA
- 3Department of Pathology and Immunology, Washington University School of Medicine, Saint Louis, MO, USA
- 4Department of Internal Medicine, Washington University School of Medicine, Saint Louis, MO, USA
- 5Bursky Center for Human Immunology and Immunotherapy Program, Washington University School of Medicine, Saint Louis, MO, USA
- 6Department of Critical Care, Missouri Baptist Medical Center, Saint Louis, MO, USA
- 7Department of Pediatrics, Washington University School of Medicine, Saint Louis, MO, USA
- 8Department of Anesthesiology, Washington University School of Medicine, Saint Louis, MO, USA
- 9Department of Surgery, Washington University School of Medicine, Saint Louis, MO, USA
- ↵*To whom correspondence should be addressed: pmudd{at}wustl.edu, Paul.thomas{at}stjude.org and ellebedy{at}wustl.edu
↵† These authors contributed equally.
Posted May 30, 2020.
Targeted Immunosuppression Distinguishes COVID-19 from Influenza in Moderate and Severe Disease
